Eelco J.P. de Koning

16.2k total citations · 4 hit papers
234 papers, 10.5k citations indexed

About

Eelco J.P. de Koning is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Genetics. According to data from OpenAlex, Eelco J.P. de Koning has authored 234 papers receiving a total of 10.5k indexed citations (citations by other indexed papers that have themselves been cited), including 137 papers in Surgery, 89 papers in Endocrinology, Diabetes and Metabolism and 80 papers in Genetics. Recurrent topics in Eelco J.P. de Koning's work include Pancreatic function and diabetes (120 papers), Diabetes and associated disorders (66 papers) and Diabetes Management and Research (57 papers). Eelco J.P. de Koning is often cited by papers focused on Pancreatic function and diabetes (120 papers), Diabetes and associated disorders (66 papers) and Diabetes Management and Research (57 papers). Eelco J.P. de Koning collaborates with scholars based in Netherlands, United States and United Kingdom. Eelco J.P. de Koning's co-authors include Ton J. Rabelink, Marten A. Engelse, Françoise Carlotti, Anne Clark, Cindy J.M. Loomans, Anton Jan van Zonneveld, Gitanjali Dharmadhikari, Alexander van Oudenaarden, Erik W.L. Jansen and Mauro J. Muraro and has published in prestigious journals such as New England Journal of Medicine, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Eelco J.P. de Koning

224 papers receiving 10.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Single-Cell Transcriptome Atlas of the Human Pancreas

2016 787 citations Mauro J. Muraro, Gitanjali Dharmadhikari et al. Cell Systems profile →
Endothelial Progenitor Cell Dysfunction

2004 708 citations Eelco J.P. de Koning, Ton J. Rabelink et al. Diabetes profile →
Unlimited in vitro expansion of adult bi-potent pancreas progenitors through the Lgr5/R-spondin axis

2013 535 citations Eelco J.P. de Koning et al. profile →
De Novo Prediction of Stem Cell Identity using Single-Cell Transcriptome Data

2016 370 citations Dominic Grün, Mauro J. Muraro et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eelco J.P. de Koning Netherlands	52	3.9k	3.9k	2.7k	2.1k	1.3k	234	10.5k
Bernhard O. Boehm Germany	59	2.8k 0.7×	3.0k 0.8×	3.7k 1.3×	2.8k 1.3×	1.3k 1.0×	307	13.7k
Donald W. Bowden United States	59	4.1k 1.0×	2.0k 0.5×	2.7k 1.0×	3.7k 1.7×	1.9k 1.5×	359	14.7k
Wataru Ogawa Japan	59	6.6k 1.7×	2.4k 0.6×	2.1k 0.8×	922 0.4×	2.4k 1.9×	323	11.8k
Koutaro Yokote Japan	47	4.6k 1.2×	2.8k 0.7×	3.6k 1.3×	528 0.2×	1.8k 1.4×	337	12.1k
Eun Jig Lee South Korea	50	2.9k 0.7×	1.3k 0.3×	3.0k 1.1×	1.3k 0.6×	851 0.7×	355	8.8k
Yasuhiko Iwamoto Japan	50	2.8k 0.7×	2.2k 0.6×	4.9k 1.8×	1.7k 0.8×	1.3k 1.0×	272	10.5k
Gian Paolo Fadini Italy	65	6.5k 1.7×	2.8k 0.7×	4.4k 1.6×	1.1k 0.5×	1.9k 1.4×	323	14.9k
Günter Wolf Germany	52	3.5k 0.9×	1.4k 0.3×	2.3k 0.8×	768 0.4×	1.0k 0.8×	359	12.3k
Katalin Suszták United States	61	8.2k 2.1×	1.8k 0.5×	1.5k 0.6×	1.9k 0.9×	1.3k 1.0×	190	16.1k
Rafael Simó Spain	68	5.0k 1.3×	1.9k 0.5×	4.1k 1.5×	708 0.3×	1.8k 1.4×	418	17.5k

Countries citing papers authored by Eelco J.P. de Koning

Since Specialization

Citations

This map shows the geographic impact of Eelco J.P. de Koning's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eelco J.P. de Koning with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eelco J.P. de Koning more than expected).

Fields of papers citing papers by Eelco J.P. de Koning

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eelco J.P. de Koning. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eelco J.P. de Koning. The network helps show where Eelco J.P. de Koning may publish in the future.

Co-authorship network of co-authors of Eelco J.P. de Koning

This figure shows the co-authorship network connecting the top 25 collaborators of Eelco J.P. de Koning. A scholar is included among the top collaborators of Eelco J.P. de Koning based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eelco J.P. de Koning. Eelco J.P. de Koning is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li‐Gao, Ruifang, Raymond Noordam, Jeroen H. P. M. van der Velde, et al.. (2025). Glycoprotein acetyls response to a mixed meal is associated with increased insulin resistance and risk of type 2 diabetes in a middle-aged population. Clinical Nutrition ESPEN. 66. 523–529.

Reichman, Trevor, James F. Markmann, Jon S. Odorico, et al.. (2025). Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes. New England Journal of Medicine. 393(9). 858–868. 9 indexed citations

Berishvili, Ekaterine, Lorenzo Piemonti, Eelco J.P. de Koning, et al.. (2024). ESOT Roadmap for Advanced Therapy Medicinal Products in Transplantation: Navigating Regulatory Challenges to Enhance Access and Care. Transplant International. 37. 13485–13485. 5 indexed citations

Koning, Eelco J.P. de, et al.. (2024). Pancreatic β-Cell Identity Change through the Lens of Single-Cell Omics Research. International Journal of Molecular Sciences. 25(9). 4720–4720. 2 indexed citations

Gröen, Nathalie, et al.. (2024). Single-cell transcriptomics reveals a role for pancreatic duct cells as potential mediators of inflammation in diabetes mellitus. Frontiers in Immunology. 15. 1381319–1381319. 4 indexed citations

Piemonti, Lorenzo, Jon S. Odorico, Timothy J. Kieffer, Valeria Sordi, & Eelco J.P. de Koning. (2023). Pluripotent Stem Cell Therapy for Diabetes. 2 indexed citations

Ruissen, Merel M., Antonio P. Arenas-de Larriva, Sasja D. Huisman, et al.. (2023). Clinical impact of an integrated e-health system for diabetes self-management support and shared decision making (POWER2DM): a randomised controlled trial. Diabetologia. 66(12). 2213–2225. 16 indexed citations

Noordstra, Ivar, Eugene A. Katrukha, Ka Lou Yu, et al.. (2022). Organization and dynamics of the cortical complexes controlling insulin secretion in β-cells. Journal of Cell Science. 135(3). 16 indexed citations

Stell, Adam L., Marten A. Engelse, Eelco J.P. de Koning, et al.. (2021). Systematic evaluation of clinically used biomaterials to determine their suitability for fabrication of beta cell delivery devices. 16. 100055–100055. 1 indexed citations

10.

Landstra, Cyril P., Axel Andrès, Mikaël Chetboun, et al.. (2021). Examination of the Igls Criteria for Defining Functional Outcomes of β-cell Replacement Therapy: IPITA Symposium Report. The Journal of Clinical Endocrinology & Metabolism. 106(10). 3049–3059. 12 indexed citations

11.

Sthijns, Mireille M.J.P.E., Marlon J. Jetten, Sandra M.H. Claessen, et al.. (2020). Oxidative stress in pancreatic alpha and beta cells as a selection criterion for biocompatible biomaterials. Biomaterials. 267. 120449–120449. 12 indexed citations

12.

Heijmans, Monique, et al.. (2019). Factors that influence the intended intensity of diabetes care in a person‐centred setting. Diabetic Medicine. 37(7). 1167–1175. 1 indexed citations

13.

Koning, Eelco J.P. de, et al.. (2019). Association between person and disease related factors and the planned diabetes care in people who receive person-centered type 2 diabetes care: An implementation study. PLoS ONE. 14(7). e0219702–e0219702. 4 indexed citations

14.

Neiman, Daniel, Joshua Moss, Merav Hecht, et al.. (2017). Islet cells share promoter hypomethylation independently of expression, but exhibit cell-type–specific methylation in enhancers. Proceedings of the National Academy of Sciences. 114(51). 13525–13530. 35 indexed citations

15.

Buitinga, Mijke, Frank P. Assen, Paul Wieringa, et al.. (2017). Micro-fabricated scaffolds lead to efficient remission of diabetes in mice. Biomaterials. 135. 10–22. 32 indexed citations

16.

Muraro, Mauro J., Gitanjali Dharmadhikari, Dominic Grün, et al.. (2016). A Single-Cell Transcriptome Atlas of the Human Pancreas. Cell Systems. 3(4). 385–394.e3. 787 indexed citations breakdown →

17.

Blok, Joris J., Volkert A.L. Huurman, Johan W. de Fijter, et al.. (2015). Thirty Years of Pancreas Transplantation at Leiden University Medical Center : Long-Term Follow-Up in a Large Eurotransplant Center. Cell Transplantation. 1 indexed citations

18.

Schulte, Barbara M., Kjerstin Lanke, Jon D. Piganelli, et al.. (2012). Cytokine and Chemokine Production by Human Pancreatic Islets Upon Enterovirus Infection. Diabetes. 61(8). 2030–2036. 49 indexed citations

19.

Kort, Hanneke de, Raghava Munivenkatappa, Stefan P. Berger, et al.. (2010). Pancreas Allograft Biopsies with Positive C4d Staining and Anti‐Donor Antibodies Related to Worse Outcome for Patients. American Journal of Transplantation. 10(7). 1669–1676. 35 indexed citations

20.

Wijk, J.P.H. van, Eelco J.P. de Koning, Manuel Castro Cabezas, et al.. (2006). Functional and Structural Markers of Atherosclerosis in Human Immunodeficiency Virus-Infected Patients. Journal of the American College of Cardiology. 47(6). 1117–1123. 89 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact